Influenza Plus (Deseret Biologicals, Inc.)


Welcome to the PulseAid listing for the Influenza Plus drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Deseret Biologicals, Inc.
NON-PROPRIETARY NAME: Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Influenzinum, Respiratory Syncytial Virus Nosode (RSV), Belladonna, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Vera
SUBSTANCE NAME: EUCALYPTUS GLOBULUS LEAF; IPECAC; ACONITUM NAPELLUS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN); ATROPA BELLADONNA; BRYONIA ALBA ROOT; EUPATO
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-09-03
END MARKETING DATE: 2019-03-11


Influenza Plus HUMAN OTC DRUG Details:

Item DescriptionInfluenza Plus from Deseret Biologicals, Inc.
LABELER NAME: Deseret Biologicals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2; 3; 3; 8; 8; 8; 30; 30; 30; 30; 30; 30([hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2014-09-03
END MARKETING DATE: 2019-03-11
PRODUCT ID: 43742-0378_ec1d36b1-b364-4656-9e0a-3da3ba43cb16
PRODUCT NDC: 43742-0378
APPLICATION NUMBER:

Other EUCALYPTUS GLOBULUS LEAF; IPECAC; ACONITUM NAPELLUS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN); ATROPA BELLADONNA; BRYONIA ALBA ROOT; EUPATO Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Influenza Plus